These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Peripheral blood stem cell autografts in pediatric cancer]. Takaue Y Gan To Kagaku Ryoho; 1990 Dec; 17(12):2307-12. PubMed ID: 1979725 [TBL] [Abstract][Full Text] [Related]
29. [Current status of the clinical application of hematopoietic growth factors in oncology]. Karthaus M; Ganser A Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692 [TBL] [Abstract][Full Text] [Related]
30. Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia. Thierry D; Gourmelon P; Parmentier C; Nénot JC Int J Radiat Biol; 1995 Feb; 67(2):103-17. PubMed ID: 7533815 [TBL] [Abstract][Full Text] [Related]
31. Hematopoietic growth factors in cancer chemotherapy. Morstyn G; Foote M; Lieschke GJ Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388 [No Abstract] [Full Text] [Related]
32. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions. Symann M Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223 [TBL] [Abstract][Full Text] [Related]
34. Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies. Stevenson HC; Klein HG Prog Clin Biol Res; 1990; 337():559-65. PubMed ID: 2353018 [No Abstract] [Full Text] [Related]
35. [Hemopoietic growth factors: their biological effects and the prospects for their clinical use]. Dexter TM Ontogenez; 1991; 22(4):341-64. PubMed ID: 1945267 [No Abstract] [Full Text] [Related]
36. [Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy]. Gianni AM; Bregni M; Siena S; Tarella C Haematologica; 1989 Oct; 74(5 Suppl):511-26. PubMed ID: 2574136 [No Abstract] [Full Text] [Related]
37. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo. Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260 [TBL] [Abstract][Full Text] [Related]
38. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas. Liem GS; Verweij J Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007 [TBL] [Abstract][Full Text] [Related]
39. [Hematopoietic growth factors]. Zwierzina H; Hoffmann S; Schmalzl F; Braunsteiner H Wien Med Wochenschr; 1991; 141(14):311-20. PubMed ID: 1949830 [TBL] [Abstract][Full Text] [Related]
40. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology]. Karthaus M; Ganser A Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]